Table 2.
# | % | |
---|---|---|
VIRAL | 61 | 35.5 |
| ||
Parainfluenza | 18 | 10.5 |
RSV | 17 | 9.9 |
Rotavirus | 16 | 9.3 |
Adenovirus | 11 | 6.4 |
Influenza | 4 | 2.3 |
Enterovirus | 4 | 2.3 |
Varicella | 3 | 1.7 |
CMV | 2 | 1.2 |
Coxsackie | 1 | 0.6 |
Rhinovirus | 1 | 0.6 |
HSV | 1 | 0.6 |
| ||
FUNGAL | 96 | 55.8 |
| ||
Thrush or candida skin infection | 74 | 43.0 |
Pneumocystis jiroveci* | 45 | 26.2 |
Aspergillus sp. | 2 | 1.2 |
| ||
BACTERIAL | 24 | 14.0 |
| ||
Pseudomonas aeruginosa | 8 | 4.7 |
Staphylococcus sp. | 5 | 2.9 |
Mycobacterial sp. | 4 | 2.3 |
Klebsiella sp. | 3 | 1.7 |
Haemophilus influenzae | 3 | 1.2 |
Streptococcus pneumoniae | 2 | 1.2 |
Escherichia coli | 2 | 1.2 |
Enterococcus sp. | 2 | 1.2 |
Listeria sp. | 1 | 0.6 |
Salmonella sp. | 1 | 0.6 |
Streptococcus viridans | 1 | 0.6 |
Moraxella sp. | 1 | 0.6 |
Chlamydia sp. | 1 | 0.6 |
Results indicate numbers of patients and percentage of total patients in which viral, fungal and bacterial agents were identified by historical report and/or laboratory reports.
In some cases, the diagnosis of Pneumocystis jiroveci was presumed by the clinical symptoms without confirmatory testing.